论文部分内容阅读
抗栓酶－３治疗脑出血恢复期５０例疗效分析广州老年病医院何衍东报道随机从脑出血病例中抽出起病２５天之后者５０例，用司威特公司生产的抗栓酶－３（Ｓｖａｔｅ－３）治疗．男３２例，女１８例，平均年龄６５．６２岁．综合组３６例，男２２例，女１４例，平均年龄６５...
Antithrombin-3 for the treatment of 50 cases of recovery of cerebral hemorrhage He Yan Dong Guangzhou Hospital of Geriatrics reported randomly from patients with cerebral hemorrhage out of 25 days after the onset of 50 cases, with the Secretary for the company’s antithrombin-3 (Svate -3) treatment. There were 32 males and 18 females, with an average age of 65.62 years. Comprehensive group of 36 patients, 22 males and 14 females, with an average age of 65 ...